A comprehensive pan-cancer analysis of the prognostic role and immunotherapy efficacy evaluation of Glyoxalase 1
This comprehensive pan-cancer study reveals the prognostic value and potential predictive role of GLO1 in immunotherapy across multiple tumor types. This study primarily utilized bioinformatic datasets; experimental validation was performed for endometrial cancer but warrants expansion to other cancer types in future work.
Authors
- Yanmei Zheng (ORCID: https://orcid.org/0000-0001-9897-2921)
- Jue Zhao (ORCID: https://orcid.org/0000-0002-1035-1790)
- Yan Zhao (ORCID: https://orcid.org/0009-0005-4105-2696)
- Qianqian Wang (ORCID: https://orcid.org/0009-0005-9308-0584)
Institutions
- Hangzhou Medical College (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-11-27
- DOI
- https://doi.org/10.1007/s12672-025-04109-3
- Primary Topic
- Advanced Glycation End Products research
- Type
- article
- Field-Weighted Citation Impact
- 0.00